U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07910968) titled 'SWitching to Appropriate Prescription in Cardiovascular-Kidney-Metabolic Syndrome' on Oct. 27.
Brief Summary: SWAP-CKM (SWitching to Appropriate Prescription in Cardiovascular-Kidney-Metabolic Syndrome) is a pragmatic, cluster-randomized clinical trial designed to evaluate whether electronic health record (EHR)-based alerts can improve medication prescribing among adults with cardiovascular, kidney, and metabolic (CKM) conditions.
The study will include all eligible adult patients receiving care within Kaiser Permanente Northern California (KPNC) who have CKM conditions and opportunities for therapeutic medication substitution. Fift...